Preclinical models trang 1 tải miễn phí từ TAILIEUCHUNG

"Preclinical models" trang 1 - tải miễn phí từ Tailieuchung

The combination of sorafenib and everolimus shows antitumor activity in preclinical models of malignant pleural mesothelioma

The combination of sorafenib and everolimus shows antitumor activity in preclinical models of malignant pleural mesothelioma

13 69 1

Anti-cancer effect and gene modulation of ET-743 in human biliary tract carcinoma preclinical models

Anti-cancer effect and gene modulation of ET-743 in human biliary tract carcinoma preclinical models

10 35 1

Isolation and characterization of two canine melanoma cell lines: New models for comparative oncology

Isolation and characterization of two canine melanoma cell lines: New models for comparative oncology

16 60 1

SITUATION MODELS AND LEVELS OF COHERENCE

SITUATION MODELS AND LEVELS OF COHERENCE

252 68 0

Báo cáo sinh học:

Báo cáo sinh học: "Pro-apoptotic activity of a-bisabolol in preclinical models of primary human acute leukemia cells"

13 32 0

Bioluminescence - Recent Advances in Oceanic Measurements and Laboratory Applications

Bioluminescence - Recent Advances in Oceanic Measurements and Laboratory Applications

200 36 0

báo cáo hóa học:

báo cáo hóa học:" Pro-apoptotic activity of a-bisabolol in preclinical models of primary human acute leukemia cells"

13 29 0

Báo cáo khoa học:

Báo cáo khoa học: "Beneficial effects of erythropoietin in preclinical models of shock and organ failure"

2 64 0

Standard Practice in Sexual Medicine

Standard Practice in Sexual Medicine

416 62 0

The New Car Assessment Program Suggested Approaches for Future Program Enhancements

The New Car Assessment Program Suggested Approaches for Future Program Enhancements

26 36 0

Assessing the translatability of In vivo cardiotoxicity mechanisms to In vitro models using causal reasoning

Assessing the translatability of In vivo cardiotoxicity mechanisms to In vitro models using causal reasoning

12 59 0

Inferring the role of the microbiome on survival in patients treated with immune checkpoint inhibitors: Causal modeling, timing, and classes of concomitant medications

Inferring the role of the microbiome on survival in patients treated with immune checkpoint inhibitors: Causal modeling, timing, and classes of concomitant medications

13 80 0

Clinical association of progesterone receptor isoform A with breast cancer metastasis consistent with its unique mechanistic role in preclinical models

Clinical association of progesterone receptor isoform A with breast cancer metastasis consistent with its unique mechanistic role in preclinical models

10 41 0

Multicentre, phase II study of eribulin in combination with S-1 in patients with advanced breast cancer

Multicentre, phase II study of eribulin in combination with S-1 in patients with advanced breast cancer

8 84 0

Antitumor activity of the polo-like kinase inhibitor, TAK-960, against preclinical models of colorectal cancer

Antitumor activity of the polo-like kinase inhibitor, TAK-960, against preclinical models of colorectal cancer

12 31 1

Serial immunomonitoring of cancer patients receiving combined antagonistic anti-CD40 and chemotherapy reveals consistent and cyclical modulation of T cell and dendritic cell parameters

Serial immunomonitoring of cancer patients receiving combined antagonistic anti-CD40 and chemotherapy reveals consistent and cyclical modulation of T cell and dendritic cell parameters

15 68 1

Oral proteasome inhibitor with strong preclinical efficacy in myeloma models

Oral proteasome inhibitor with strong preclinical efficacy in myeloma models

10 48 1

Microarray profiling shows distinct differences between primary tumors and commonly used preclinical models in hepatocellular carcinoma

Microarray profiling shows distinct differences between primary tumors and commonly used preclinical models in hepatocellular carcinoma

10 42 1

A small molecular agent YL529 inhibits VEGF-D-induced lymphangiogenesis and metastasis in preclinical tumor models in addition to its known antitumor activities

A small molecular agent YL529 inhibits VEGF-D-induced lymphangiogenesis and metastasis in preclinical tumor models in addition to its known antitumor activities

12 33 1

Predicting response to multidrug regimens in cancer patients using cell line experiments and regularised regression models

Predicting response to multidrug regimens in cancer patients using cell line experiments and regularised regression models

15 36 1

Đã phát hiện trình chặn quảng cáo AdBlock

Trang web này phụ thuộc vào doanh thu từ số lần hiển thị quảng cáo để tồn tại. Vui lòng tắt trình chặn quảng cáo của bạn hoặc tạm dừng tính năng chặn quảng cáo cho trang web này.